Antares, Ferring deal

Ferring received exclusive rights to IP covering Antares' transdermal gel delivery technology and purchased certain Antares assets, including research equipment and Antares' development facility in Allschwil, Switzerland. Antares said the deal aligns with its plans save cash and focus on its parenteral injector products, including its Vibex autoinjector. Antares will receive an undisclosed upfront payment and is eligible for milestones related to the transdermal delivery technology. ...